• ქართული
  • English
  • U.S. judge rules for Regeneron, Sanofi in Amgen cholesterol drug patent fight

    A U.S. judge on Wednesday set aside a jury verdict that found Amgen Inc patents on its cholesterol drug Repatha were valid, handing a victory to Regeneron Pharmaceuticals Inc and Sanofi SA , which sells a rival drug.

    Market Quotes by TradingView